Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
McCullough, Laurence B. Chervenak, Frank A. Brent, Robert L. and Hippen, Benjamin 2010. A Case Study in Unethical Transgressive Bioethics: “Letter of Concern from Bioethicists” About the Prenatal Administration of Dexamethasone. The American Journal of Bioethics, Vol. 10, Issue. 9, p. 35.
Minghetti, Paola Palmieri, Iolanda and Selmin, Francesca 2010. When authorized medicinal products are not available: possible alternatives to meet legitimate expectations of patients. Journal of Pharmaceutical Health Services Research, Vol. 1, Issue. 3, p. 107.
Hyun, Insoo 2010. Allowing Innovative Stem Cell-Based Therapies outside of Clinical Trials: Ethical and Policy Challenges. Journal of Law, Medicine & Ethics, Vol. 38, Issue. 2, p. 277.
Malek, Antoine and Mattison, Donald R 2010. Drug development for use during pregnancy: impact of the placenta. Expert Review of Obstetrics & Gynecology, Vol. 5, Issue. 4, p. 437.
Frader, Joel 2010. Speaking of Accuracy. The American Journal of Bioethics, Vol. 10, Issue. 9, p. 52.
Martin, Caren McHenry 2010. Off-Label Use of Medications: Innovative Prescribing or Risky Business?. The Consultant Pharmacist, Vol. 25, Issue. 12, p. 806.
Guidi, Benedetta Nocco, Luca Rizzi, Marco and Walbaum Robinson, Isabel A. 2011. Opinio Juris in Comparatione Vol. 1/2011. SSRN Electronic Journal,
Scott Morton, Fiona and Kyle, Margaret 2011. Vol. 2, Issue. , p. 763.
Van Allen, Eliezer M. Miyake, Todd Gunn, Nathan Behler, Caroline M. and Kohlwes, Jeff 2011. Off-Label Use of Rituximab in a Multipayer Insurance System. Journal of Oncology Practice, Vol. 7, Issue. 2, p. 76.
Berland-Benhaïm, C Giocanti, D Bartoli, C Sastre, C Leonetti, G and Pelissier-Alicot, Al 2011. Medication misuse and abuse: duties and responsibilities of dispensing pharmacists. Medicine, Science and the Law, Vol. 51, Issue. 1, p. 49.
Brody, Howard and Light, Donald W. 2011. The Inverse Benefit Law: How Drug Marketing Undermines Patient Safety and Public Health. American Journal of Public Health, Vol. 101, Issue. 3, p. 399.
Devane, C. Lindsay 2012. Pharmacotherapy of Child and Adolescent Psychiatric Disorders. p. 25.
Wittich, Christopher M. Burkle, Christopher M. and Lanier, William L. 2012. Ten Common Questions (and Their Answers) About Off-label Drug Use. Mayo Clinic Proceedings, Vol. 87, Issue. 10, p. 982.
Ghinea, N. Lipworth, W. Kerridge, I. and Day, R. 2012. No evidence or no alternative? Taking responsibility for off‐label prescribing. Internal Medicine Journal, Vol. 42, Issue. 3, p. 247.
Underhill, Kristen 2012. Paying for Prevention: Challenges to Health Insurance Coverage for Biomedical HIV Prevention in the United States. American Journal of Law & Medicine, Vol. 38, Issue. 4, p. 607.
Mellor, J. D. Van Koeverden, P. Yip, S. W. K. Thakerar, A. Kirsa, S. W. and Michael, M. 2012. Access to anticancer drugs: many evidence‐based treatments are off‐label and unfunded by the Pharmaceutical Benefits Scheme. Internal Medicine Journal, Vol. 42, Issue. 11, p. 1224.
Ruble, James 2012. Off-Label Prescribing of Medications for Pain: Maintaining Optimal Care at an Intersection of Law, Public Policy, and Ethics. Journal of Pain & Palliative Care Pharmacotherapy, Vol. 26, Issue. 2, p. 146.
Lowenthal, Justin Hull, Sara Chandros and Pearson, Steven D. 2012. The Ethics of Early Evidence — Preparing for a Possible Breakthrough in Alzheimer's Disease. New England Journal of Medicine, Vol. 367, Issue. 6, p. 488.
Dreger, Alice Feder, Ellen K. and Tamar-Mattis, Anne 2012. Prenatal Dexamethasone for Congenital Adrenal Hyperplasia. Journal of Bioethical Inquiry, Vol. 9, Issue. 3, p. 277.
Cole, Lindsay W. Kesselheim, Jennifer C. and Kesselheim, Aaron S. 2012. Ethical Issues in New Drug Prescribing. Journal of Bioethical Inquiry, Vol. 9, Issue. 1, p. 77.